Close Menu

NEW YORK (GenomeWeb) – Cambridge, UK-based human cell products provider DefiniGen said today it has licensed CRISPR-Cas9 genome editing technology from the Broad Institute to develop human cell disease models.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.